SAPIRSTEIN JAMES 4
4 · ZyVersa Therapeutics, Inc. · Filed Jul 18, 2024
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
Director
Transactions
- Award
Stock Options
2023-05-24+132→ 132 totalExercise: $152.46Exp: 2033-05-24→ Common Stock (132 underlying)
Footnotes (3)
- [F1]The option disclosed on this Form 4 was not previously reported due to an administrative oversight.
- [F2]Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024.
- [F3]The option vests annually in three equal installments commencing on May 24, 2024.